FRAGMIN is a low molecular weight heparin (LMWH) indicated for, Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness, Extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in adult patients with cancer.
From the U.S. FDA-approved label for Dalteparin sodium. Full label: DailyMed.
FRAGMIN is a low molecular weight heparin (LMWH) indicated for, Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness, Extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in adult patients with cancer. In these patients, the FRAGMIN therapy begins with the initial VTE treatment and continues for six months, Treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in pediatric patients from birth (gestational age at least 35 weeks).
From the U.S. FDA-approved label for Dalteparin sodium. Full label: DailyMed.
Treatment should be continued until the patient is clinically stabilized. The usual duration of administration is 5 days to 8 days. Concurrent aspirin therapy is recommended except when contraindicated.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
FRAGMIN is contraindicated in: Patients with active major bleeding., Patients with a history of heparin induced thrombocytopenia or heparin induced thrombocytopenia with thrombosis., Patients with prior hypersensitivity to dalteparin sodium (e.g., pruritis, rash, anaphylactic reactions)., Patients undergoing Epidural/Neuraxial anesthesia, do not administer FRAGMIN; o As a treatment for unstable angina and non-Q-wave MI.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Hemorrhage: Use caution in conditions with increased risk of hemorrhage, Thrombocytopenia: Monitor thrombocytopenia of any degree closely, Benzyl Alcohol Preservative: Do not use multiple-dose formulations in neonates and infants as they contain benzyl alcohol, Laboratory Tests: Periodic blood counts recommended 5.1 Risk of Hemorrhage including Spinal/Epidural Hematomas Spinal or epidural hemorrhage and subsequent hematomas can occur with the associated use of low molecular weight heparins or heparinoids and neuraxial (spinal/epidural) anesthesia or spinal puncture.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described in more detail in other sections of the prescribing information., Risk of Hemorrhage including Spinal/Epidural Hematomas, Thrombocytopenia, Benzyl Alcohol Preservative Risk to Premature Infants Most common adverse reactions (>1%) are: bleeding (including hemorrhage), thrombocytopenia (Type I), hematoma at the injection site, pain at the injection site,…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
14 products from 6 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Daltehep 2500IU Injection | Dalteparin Sodium (2500IU) | Gland Pharma Pvt. Ltd. | |
| Daltehep 5000IU Injection | Dalteparin Sodium (5000IU) | Gland Pharma Pvt. Ltd. | |
| Fragmin 100000 IU Injection | Dalteparin Sodium (100000 IU) | Pharmaco | |
| Fragmin 2500 IU Injection | Dalteparin Sodium (2500 IU) | Pharmaco | |
| Fragmin 5000 IU Injection | Dalteparin Sodium (5000 IU) | Pharmaco | |
| Fragmin 7500IOU Injection | Dalteparin Sodium (7500IOU) | Pharmaco | |
| Dalpin 2500IU Injection | Dalteparin (2500IU) | United Biotech Pvt Ltd | vial of 1 ml Injection |
| Daltehep 10000IU Injection | Dalteparin (10000IU) | Gland Pharma Limited | vial of 10 ml Injection |
| Daltepin 10000IU Injection | Dalteparin (10000IU) | Intas Pharmaceuticals Ltd | vial of 1 ml Injection |
| Daltepin 2500IU Injection | Dalteparin (2500IU) | Intas Pharmaceuticals Ltd | vial of 1 ml Injection |
| Daltepin 5000IU Injection | Dalteparin (5000IU) | Intas Pharmaceuticals Ltd | vial of 1 ml Injection |
| Fragmin 10000IU Injection | Dalteparin (10000IU) | Pfizer Ltd | prefilled syringe of 1 ml Injection |
| Fragmin 2500IU Injection | Dalteparin (2500IU) | Pfizer Ltd | prefilled syringe of 0.2 ml Solution for Injection |
| Fragmin 5000IU Injection | Dalteparin (5000IU) | Pfizer Ltd | prefilled syringe of 0.2 ml Solution for Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20°C to 25°C (68°F to 77°F); excursion permitted between 15°C to 30°C (59°F to 86°F). Latex Allergy: The needle shield of the prefilled syringe may contain natural rubber latex.
Storage information from the U.S. FDA-approved label.
Dalteparin sodium is recorded in the NepalDoc medicine catalog for: Unstable angina, Pulmonary embolism, Deep-vein thrombosis, Prophylaxis of clotting in extracorporeal circulation in haemodialysis or haemofiltration, Prophylaxis of venous thromboembolism during surgery.
For Unstable angina: Enoxaparin, Eptifibatide, Heparin sodium.
For Pulmonary embolism: Heparin sodium.
For Deep-vein thrombosis: Heparin sodium.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
